122 related articles for article (PubMed ID: 6198119)
21. Adoptive transfer of experimental allergic encephalomyelitis: conditions influencing memory and effector cell development.
Bouwer HG; Dietsch GN; Hinrichs DJ
Cell Immunol; 1990 Nov; 131(1):219-31. PubMed ID: 1699673
[TBL] [Abstract][Full Text] [Related]
22. Activation of an encephalitogenic T lymphocyte line with a cellfree supernatant containing basic protein and I region gene products.
Vandenbark AA; Teal P; Offner H
J Immunol; 1987 Jan; 138(2):452-9. PubMed ID: 2432125
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune encephalomyelitis (EAE) mediated or prevented by T lymphocyte lines directed against diverse antigenic determinants of myelin basic protein. Vaccination is determinant specific.
Holoshitz J; Frenkel A; Ben-Nun A; Cohen IR
J Immunol; 1983 Dec; 131(6):2810-3. PubMed ID: 6196400
[TBL] [Abstract][Full Text] [Related]
24. Recipient contributions to serial passive transfer of experimental allergic encephalomyelitis.
Wegmann KW; Hinrichs DJ
J Immunol; 1984 May; 132(5):2417-23. PubMed ID: 6201543
[TBL] [Abstract][Full Text] [Related]
25. Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein.
Sakai K; Sinha AA; Mitchell DJ; Zamvil SS; Rothbard JB; McDevitt HO; Steinman L
Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8608-12. PubMed ID: 2460872
[TBL] [Abstract][Full Text] [Related]
26. Myelin basic protein-specific T lymphocytes induce chronic relapsing experimental autoimmune encephalomyelitis in lymphocyte-deficient (SCID) mice.
Jones RE; Mass M; Bourdette DN
J Neuroimmunol; 1999 Jan; 93(1-2):92-101. PubMed ID: 10378872
[TBL] [Abstract][Full Text] [Related]
27. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
[TBL] [Abstract][Full Text] [Related]
28. Alterations in T cell antigen specificity and class II restriction during the course of chronic relapsing experimental allergic encephalomyelitis.
McCarron RM; Fallis RJ; McFarlin DE
J Neuroimmunol; 1990; 29(1-3):73-9. PubMed ID: 1698817
[TBL] [Abstract][Full Text] [Related]
29. Suppressor cell regulation of encephalitogenic T cell lines: generation of suppressor macrophages with cyclosporin A and myelin basic protein.
Whitham RH; Vandenbark AA; Bourdette DN; Chou YK; Offner H
Cell Immunol; 1990 Apr; 126(2):290-303. PubMed ID: 1690080
[TBL] [Abstract][Full Text] [Related]
30. Two minor determinants of myelin basic protein induce experimental allergic encephalomyelitis in SJL/J mice.
Kono DH; Urban JL; Horvath SJ; Ando DG; Saavedra RA; Hood L
J Exp Med; 1988 Jul; 168(1):213-27. PubMed ID: 2456367
[TBL] [Abstract][Full Text] [Related]
31. T cells in the lesion of experimental autoimmune encephalomyelitis. Enrichment for reactivities to myelin basic protein and to heat shock proteins.
Mor F; Cohen IR
J Clin Invest; 1992 Dec; 90(6):2447-55. PubMed ID: 1281835
[TBL] [Abstract][Full Text] [Related]
32. Induction and suppression of an autoimmune disease by oligomerized T cell epitopes: enhanced in vivo potency of encephalitogenic peptides.
Falk K; Rötzschke O; Santambrogio L; Dorf ME; Brosnan C; Strominger JL
J Exp Med; 2000 Feb; 191(4):717-30. PubMed ID: 10684863
[TBL] [Abstract][Full Text] [Related]
33. Characterization of basic protein-specific T cell lines selected from Lewis rats with relapsing experimental autoimmune encephalomyelitis.
Bourdette DN; Turner MJ; Vandenbark AA; Offner H
J Neuroimmunol; 1990 Jan; 26(1):81-5. PubMed ID: 1688445
[TBL] [Abstract][Full Text] [Related]
34. Autoaggressive T lymphocyte lines recognizing the encephalitogenic region of myelin basic protein: in vitro selection from unprimed rat T lymphocyte populations.
Schluesener HJ; Wekerle H
J Immunol; 1985 Nov; 135(5):3128-33. PubMed ID: 2413113
[TBL] [Abstract][Full Text] [Related]
35. Induction of experimental autoimmune encephalomyelitis by native myelin basic protein-activated T lymphocyte lines.
Friedman A; Reshef T; Cohen IR
Eur J Immunol; 1992 Jan; 22(1):279-82. PubMed ID: 1370416
[TBL] [Abstract][Full Text] [Related]
36. Delayed, relapsing experimental allergic encephalomyelitis in mice. Role of adjuvants and pertussis vaccine.
Lublin FD
J Neurol Sci; 1982; 57(1):105-10. PubMed ID: 7153781
[TBL] [Abstract][Full Text] [Related]
37. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
[TBL] [Abstract][Full Text] [Related]
38. Recovery mechanisms from experimental allergic encephalomyelitis in rats: analyses by using encephalitogenic T cell line.
Namikawa T; Satoh J; Yamamura T; Sakai K; Kunishita T; Tabira T
Int Arch Allergy Appl Immunol; 1987; 83(4):366-70. PubMed ID: 2440815
[TBL] [Abstract][Full Text] [Related]
39. Prevention of experimental allergic encephalomyelitis (EAE) in the SJL/J mouse by whole body ultraviolet irradiation.
Hauser SL; Weiner HL; Che M; Shapiro ME; Gilles F; Letvin NL
J Immunol; 1984 Mar; 132(3):1276-81. PubMed ID: 6363536
[TBL] [Abstract][Full Text] [Related]
40. Bacterial agents protect against autoimmune disease. I. Mice pre-exposed to Bordetella pertussis or Mycobacterium tuberculosis are highly refractory to induction of experimental autoimmune encephalomyelitis.
Lehmann D; Ben-Nun A
J Autoimmun; 1992 Dec; 5(6):675-90. PubMed ID: 1489483
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
